The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer

Genetics in Medicine

Volumn 10, Issue 6, 2008, Pages 430-438

  Cowan, Ruth ^a,b   Meiser, Bettina ^c,d   Giles, Graham G ^e   Lindeman, Geoffrey J ^b   Gaff, Clara L ^b,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f Genetic Health Services Victoria   (Australia)

Author keywords

Genetic services; Genetic testing; Health behavior; Hereditary cancer syndrome; Men; Prevention; Prostate cancer

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CANCER RISK; DIET; DISEASE SURVEILLANCE; EXERCISE; FAMILY HISTORY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; MALE; MINERAL INTAKE; NORMAL HUMAN; PROSTATE CANCER; QUESTIONNAIRE; RISK REDUCTION; SMOKING; VITAMIN SUPPLEMENTATION; ATTITUDE TO HEALTH; FAMILY HEALTH; GENETIC PREDISPOSITION; MIDDLE AGED; PATIENT ATTITUDE; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; RISK; SOCIOECONOMICS;

AGED; ATTITUDE TO HEALTH; DIET; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; RISK; SOCIOECONOMIC FACTORS;

EID: 48849089255     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31817701c1     Document Type: Article

References (55)

1. Lantz JM, Fullerton JT, Harshburger RJ, Sadler GR. Promoting screening and early detection of cancer in men. Nurs Health Sci 2001;3:189-196.
2. Smith JA, Braunack-Mayer A, Wittert G. What do we know about men's help-seeking and health service use? Med J Aust 2006;184:81-83.
3. Marteau TM, Croyle RT. The new genetics. Psychological responses to genetic testing. BMJ 1998;316:693-696.
4. Meiser B, Collins V, Warren R, Gaff C, et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004;66:502-511.
5. Department of Health (UK). Our inheritance, our future: realising the potential of genetics in the NHS. Stationary Office, 2003.
6. Collins VR, Meiser B, Ukoumunne OC, Gaff C, et al. The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med 2007;9:290-297.
7. Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A. Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer 2007;121:225-231.
8. Lindor NM, Petersen GM, Hadley DW, Kinney AY, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:1507-1517.
9. Bratt O. Hereditary prostate cancer. BJU Int 2000;85:588-598.
10. Albertsen PC. Is screening for prostate cancer with prostate specific antigen an appropriate public health measure? Acta Oncol 2005;44:255-264.
11. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276:1957-1963.
12. Lippman SM, Goodman PJ, Klein EA, Parnes HL, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005;97: 94-102.
13. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, et al. The influence of finas-teride on the development of prostate cancer. N Engl J Med 2003;349:215-224.
14. Scardino PT. The prevention of prostate cancer-the dilemma continues. N Engl J Med 2003;349:297-299.
15. Moyad MA, Carroll PR. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? Urol Clin North Am 2004;31:301-311.
16. Moyad MA, Carroll PR. Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? Urol Clin North Am 2004;31:289-300.
17. Biesecker BB, Marteau TM. The future of genetic counselling: an international perspective. Nat Genet 1999;22:133-137.
18. Shiloh S. Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns 2006;15:325-337.
19. Michie S, Smith JA, Senior V, Marteau TM. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet 2003;119A:340-347.
20. Michie S, Weinman J, Miller J, Collins V, et al. Predictive genetic testing: high risk expectations in the face of low risk information. J Behav Med 2002;25:33-50.
21. Shiloh S, Ben-sinai R, Keinan G. Effects of controllability, predictability and information-seeking style on interest in predictive genetic testing. Pers Soc Pychol Bull 1999;25:1187-1195.
22. Miller SM. Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 1987;52:345-353.
23. Staples MP, Giles GG, English DR, McCredie MR, et al. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control 2003;14:161-166.
24. Gaff CL, Aragona C, MacInnis RJ, Cowan R, et al. Accuracy and completeness in reporting family history of prostate cancer by unaffected men. Urology 2004;63: 1111-1116.
25. Gaff CL, Cowan R, Meiser B, Lindeman G. Genetic services for men: the preferences of men with a family history of prostate cancer. Genet Med 2006;8:771-778.
26. Meiser B, Cowan R, Costello A, Giles GG, et al. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake. Urology 2007;70:738-742.
27. Streiner DL, Norman GR. Health measurement scales. Oxford: Oxford University Press, 1995.
28. Valdimarsdottir H, Bovbjerg D, Kash K, Holland J, et al. Psychological distress in women with a familial risk of breast cancer. Psychooncology 1995;4:133-141.
29. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, Borgen P, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 1997;19:362-369.
30. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
31. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 2000;36:235-241.
32. Meiser B, Butow P, Barratt A, Friedlander M, et al. Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 2000;59:101-111. (Pubitemid 30216133)
33. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
34. Ibbotson T, Maguire P, Selby P, Priestman T, et al. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994; 30A:37-40.
35. Moorey S, Greer S, Watson M, Gorman C, et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255-259.
36. Ropka ME, Wenzel J, Phillips EK, Siadaty M, et al. Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev 2006;15:840-855.
37. Cooper AF. Whose illness is it anyway? Why patient perceptions matter. Int J Clin Pract 1998;52:551-556.
38. Doukas DJ, Fetters MD, Coyne JC, McCullough LB. How men view genetic testing for prostate cancer risk: findings from focus groups. Clin Genet 2000;58:169-176.
39. Diefenbach MA, Schnoll RA, Miller SM, Brower L. Genetic testing for prostate cancer. Willingness and predictors of interest. Cancer Pract 2000;8:82-86.
40. Myers RE, Hyslop T, Jennings-Dozier K, Wolf TA, et al. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev 2000;9:1323-1328.
41. Cormier L, Valeri A, Azzouzi R, Fournier G, et al. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 2002;51:276-285.
42. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997;50:360-365.
43. Doukas DJ, Li Y. Men's values-based factors on prostate cancer risk genetic testing: a telephone survey. BMC Med Genet 2004;5:28.
44. Weinrich S, Royal C, Pettaway CA, Dunston G, et al. Interest in genetic prostate cancer susceptibility testing among African American men. Cancer Nurs 2002;25: 28-34.
45. Rees G, Fry A, Cull A, Sutton S. Illness perceptions and distress in women at increased risk of breast cancer Psych Health 2004;19:749-765.
46. Gooding HC, Organista K, Burack J, Biesecker BB. Genetic susceptibility testing from a stress and coping perspective. Soc Sci Med 2006;62:1880-1890.
47. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 2006;62:1360-1368.
48. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005;14:1060-1074.
49. Marteau T, Senior V, Humphries SE, Bobrow M, et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet A 2004;128:285-293.
50. Giles GG, Severi G, English DR, McCredie MR, et al. Sexual factors and prostate cancer. BJU Int 2003;92:211-216.
51. Lobb E, Hallowell N, Pepall E, Kristjanson L, et al. What do men want?: the expectations of the familial clinic of men from high risk breast cancer families. Psy-chooncology 2006;15:S1-S478.
52. Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: psychological aspects and implications. J Consult Clin Psychol 2002;70:784-797.
53. Balmana J, Stoffel EM, Emmons KM, Garber JE, et al. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet 2004;41:e44.
54. Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-behavior change in primary care. Am J Prev Med 1999;17:275-284.
55. Jepson R. The effectiveness of interventions to change health-related behaviours: a review of reviews. Glasgow: Medical Research Council, MRC Social & Public Health Sciences Unit, University of Glasgow, 2000.